Management of growth retardation in juvenile idiopathic arthritis
- PMID: 18174727
- DOI: 10.1159/000110605
Management of growth retardation in juvenile idiopathic arthritis
Abstract
Background: Inflammation and glucocorticoid therapy are major factors in the growth retardation seen in children with severe forms of juvenile idiopathic arthritis (JIA). It has been recently shown that tumor necrosis factor (TNF)-alpha antagonist therapy can improve growth velocity in JIA patients; however, the recombinant human soluble TNF-alpha receptor fusion protein etanercept has had limited efficacy in systemic forms of JIA. For several years, growth hormone (GH) has been used to treat growth retardation in patients with JIA receiving glucocorticoids. GH treatment can normalize growth velocity and prevent the severe loss of height; however, catch-up growth markedly varies with the severity of the inflammatory state and the steroid doses used during GH treatment. Recently, early institution of GH treatment has been shown to maintain normal growth in children with JIA.
Conclusions: These promising results show the need for careful monitoring of growth in children with JIA, the utility of GH therapy before the onset of severe growth delay and the potential for preservation of long-term growth during disease progression.
Copyright (c) 2007 S. Karger AG, Basel.
Similar articles
-
Linear growth in children suffering from juvenile idiopathic arthritis requiring steroid therapy: natural history and effects of growth hormone treatment on linear growth.J Pediatr Endocrinol Metab. 2001;14 Suppl 6:1483-6. J Pediatr Endocrinol Metab. 2001. PMID: 11837503 Review.
-
Effects of growth hormone treatment in juvenile idiopathic arthritis: bone and body composition.Horm Res. 2009 Nov;72 Suppl 1:60-4. doi: 10.1159/000229766. Epub 2009 Nov 27. Horm Res. 2009. PMID: 19940498 Review.
-
Effects of growth hormone treatment on growth in children with juvenile idiopathic arthritis.Horm Res. 2009 Nov;72 Suppl 1:55-9. doi: 10.1159/000229765. Epub 2009 Nov 27. Horm Res. 2009. PMID: 19940497 Review.
-
Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids.J Rheumatol. 2002 Jun;29(6):1296-300. J Rheumatol. 2002. PMID: 12064849
-
Children with oligoarticular juvenile idiopathic arthritis are at considerable risk for growth retardation.J Pediatr. 2011 Nov;159(5):832-837.e1-2. doi: 10.1016/j.jpeds.2011.04.012. Epub 2011 May 31. J Pediatr. 2011. PMID: 21621220
Cited by
-
Nutritional Aspects of Juvenile Idiopathic Arthritis: An A to Z for Dietitians.Children (Basel). 2023 Jan 23;10(2):203. doi: 10.3390/children10020203. Children (Basel). 2023. PMID: 36832332 Free PMC article. Review.
-
Long-term results of children diagnosed with idiopathic nephrotic syndrome; single center experience.Turk Pediatri Ars. 2015 Mar 1;50(1):37-44. doi: 10.5152/tpa.2015.2086. eCollection 2015 Mar. Turk Pediatri Ars. 2015. PMID: 26078695 Free PMC article.
-
Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009.J Rheumatol. 2013 Jul;40(7):1218-25. doi: 10.3899/jrheum.120661. Epub 2013 Apr 15. J Rheumatol. 2013. PMID: 23588938 Free PMC article.
-
The effect of colchicine on physical growth in children with familial mediterranean fever.Eur J Pediatr. 2010 Jul;169(7):825-8. doi: 10.1007/s00431-009-1120-z. Epub 2009 Dec 17. Eur J Pediatr. 2010. PMID: 20016916
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
